Prestige Consumer Closes LaCorium Acquisition; Prices $400M Senior Notes

Prestige Consumer Healthcare Inc. has completed the acquisition of LaCorium Health for approximately $150 million in cash, financed by cash on hand and existing credit facilities. LaCorium Health, an Australian therapeutic skin care leader, is expected to generate approximately $40 million in annual revenue and $12 million in EBITDA post-integration. Additionally, the company priced a private offering of $400 million in 6.25% senior notes due 2034, with proceeds intended to redeem existing 5.125% senior notes due January 2028. Prestige will report its first quarter fiscal 2027 results on August 6, 2026.